X0609 4 2026-05-15 0 0001549595 Nurix Therapeutics, Inc. NRIX 0001680739 Baynes Roy D. false C/O NURIX THERAPEUTICS, INC. 1600 SIERRA POINT PKWY BRISBANE CA 94005 1 0 0 0 0 Director Stock Option (right to buy) 15.86 2026-05-15 4 A 0 31250 0 A 2036-05-14 Common Stock 31250 31250 D The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 15, 2027, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date. /s/ Daniel Burbach, as Attorney-in-Fact for Roy D. Baynes 2026-05-15